Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Beckman Coulter — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

269 daysmedian FDA review time
326 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K232904Access OstaseBeckman Coulter2024-04-152100
K193124Unicel DxH 800 Coulter Cellular Analysis SystemBeckman Coulter2020-04-161561
K182886Cytomics FC 500 Series (MPL or MCL) Flow CytometerBeckman Coulter2019-09-063260
K183592ClearLLab 10C Panels (B, T, M1, M2), Navios Flow Cytometer, Beckman Coulter2019-03-21900
K181599Unicel DxH 800 Cellular Analysis System with Early Sepsis InBeckman Coulter2019-03-182730
K181475DxH 520 Hematology InstrumentBeckman Coulter2019-03-012700
DEN160047ClearLLab T1, ClearLLab T2, ClearLLab B1, ClearLLab B2, CleaBeckman Coulter2017-06-292690
K162897Navios EX Flow Cytometer, 6 Color/2 Laser, Navios EX Flow CyBeckman Coulter2017-06-232490

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda